Main Symposium

Day 1 – 20 October 2018

Day 2 – 21 October 2018

Time Session Speaker Country
07:45 – 08:30 Registration
08:30 – 08:45 Opening Ceremony and Speeches
Plenary 1
08:45 – 09:15 Leading a Successful LDLT Programme – The Western Perspective Nancy Asher USA
Surgical Track
09:15 – 09:35 Bariatric Surgery and liver transplantation: Should it be done? Iyer Shridhar Singapore
09:35 – 09:55 Innovative Surgical Techniques in LDLT Albert Chan Hong Kong
09:55 – 10:15 Putting the donor at the center to grow transplant volume and improve follow up Claus Niemann USA
10:15 – 10:35 The role of organ perfusion machines in liver transplantation Glenn Bonney Singapore
10:35 – 10:50 Q&A
10:50 – 11:05 Tea Break
Medical Track
11:05 – 11:25 Pre-LT renal impairment and HRS James Fung Hong Kong
11:25 – 11:45 Not so sweet news: NODAT in Liver Transplantation Vathsala A Singapore
11:45 – 12:05 Post-transplant NASH – prevention and management George Goh Singapore
12:05 – 12:25 Metabolic syndrome after paediatric liver transplantation: is it an issue? Marion Aw Singapore
12:25 – 12:40 Q&A
12:40 – 13:10 Lunch Break
Plenary 2: ILTS/TTS Donor Summit (International Liver Transplant Society/ The Transplantation Society)
Introduction to the Living Donor Liver Summit
Donor Summit Part 1 — Background and Ethical Considerations
13:10 – 13:30 Global Living Donor Transplant Activity Nancy Asher USA
13:30 – 13:50 The Importance of Donor Protection in LDLT — the surgical perspective Albert Chan Hong Kong
13:50 – 14:10 Ethics of Living Donation — From The Liver Perspectives Elizabeth Pomfret USA
14:10 – 14:30 Enhancing our commitment to patient safety – perspectives on oversight and governance for organ transplantation in Singapore Kenneth Mak Singapore
14:30 – 14:50 Evaluating suitability of donors — from the Transplant Ethics Committee perspective Agnes Ng Singapore
14:50 – 15:05 Break
Donor Summit Part 2 — Management of Donor
15:05 – 15:25 MIS harvesting of donor liver — What is the current status? Choi Gyu-Seong South Korea
15:25 – 15:45 Long-term Follow up & Registries of Living Donation Activities — What is the implication? Claus Niemann USA
15:45 – 16:15 Managing difficult liver donor situation in LDLT setting Wang Chi Chi Taiwan
16:15 – 17:00 Case Discussion: Ethics of donor evaluation — eg risk with donor HIV partners, HCC recipient out of criteria, HCC within criteria Alfred Kow Singapore
17:00 End of Day 1
Time Session Speaker Country
Plenary 3
08:30 – 09:00 Key to a successful LDLT programme — The Eastern Perspective Wang Chih-Chi Taiwan
Liver Malignancy Track
09:00 – 09:20 Immunotherapy for HCC – Where we are now and where we’re going? Yong Wei Peng Singapore
09:20 – 09:40 Is there a role to downstage HCC with SIRT before LT? Pierce Chow Singapore
09:40 – 10:00 Expanded HCC criteria for LT – Is there a limit? Tan Poh Seng Singapore
10:00 – 10:20 Incidental mixed Cholangio-HCC on LT explant: How do we make sense of it? Elizabeth Pomfret USA
10:20 – 10:35 Q&A
10:35 – 10:50 Tea Break
High Risk Liver Recipients
10:50 – 11:10 Controversies in management of ALF patients Lee Guan Huei Singapore
11:10 – 11:30 Acute on Chronic Liver Failure – when is transplant futile? Singapore
11:30 – 11:50 Pre-liver transplant multi-resistant organisms and opportunistic infections — How do we handle them? Tan Ban Hock Singapore
11:50 – 12:10 Technical challenges in complex vascular reconstruction in LDLT Choi Gyu-Seong South Korea
12:10 – 12:30 Q&A
12:30 End of Programme

Programme updated as of 16 August 2018.